Kedrion Biopharma

Kedrion Biopharma Inc. announced that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of a new immunoglobulin therapy in the U.S. With the expected market growth in the U.S., distributing this therapy allows Kedrion to remain at the forefront of meeting this market need and reaching more patients. Learn more about Kedrion’s role: https://lnkd.in/dZG6dhyZ

🌍👶𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐧𝐠 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐃𝐚𝐲:  𝐭𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 "𝑊𝑒 𝑎𝑟𝑒 𝑣𝑒𝑟𝑦 𝑝𝑟𝑜𝑢𝑑 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑖𝑚𝑝𝑎𝑐𝑡 𝑜𝑓 𝑛𝑒𝑤𝑏𝑜𝑟𝑛 𝑠𝑐𝑟𝑒𝑒𝑛𝑖𝑛𝑔 𝑤𝑒 𝑒𝑥𝑒𝑐𝑢𝑡𝑒 𝑎𝑡 𝑀𝑒𝑦𝑒𝑟 𝐻𝑜𝑠𝑝𝑖𝑡𝑎𝑙. 𝐼𝑡 𝑎𝑙𝑙𝑜𝑤𝑠 𝑢𝑠 𝑡𝑜 𝑝𝑟𝑜𝑣𝑖𝑑𝑒 𝑎 𝑠𝑒𝑐𝑜𝑛𝑑 𝑐ℎ𝑎𝑛𝑐𝑒 𝑡𝑜 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝑤𝑖𝑡ℎ 𝐼𝑚𝑚𝑢𝑛𝑜𝑑𝑒𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑖𝑒𝑠. 𝑊𝑒 𝑎𝑟𝑒 𝑐𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑡 𝑡ℎ𝑎𝑡 𝑓𝑢𝑡𝑢𝑟𝑒 𝑖𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑙𝑙 𝑒𝑛𝑎𝑏𝑙𝑒 𝑢𝑠 𝑡𝑜 ℎ𝑒𝑙𝑝 𝑒𝑣𝑒𝑛 𝑚𝑜𝑟𝑒 𝑖𝑛𝑓𝑎𝑛𝑡𝑠, 𝑒𝑛𝑠𝑢𝑟𝑖𝑛𝑔 ℎ𝑒𝑎𝑙𝑡ℎ𝑖𝑒𝑟 𝑎𝑛𝑑 𝑏𝑟𝑖𝑔ℎ𝑡𝑒𝑟 𝑓𝑢𝑡𝑢𝑟𝑒 𝑓𝑜𝑟 𝑡ℎ𝑒𝑚 𝑎𝑙𝑙." Today, on International Neonatal Screening Day, we are proud to share a 𝗿𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝘁𝗲𝘀𝘁𝗶𝗺𝗼𝗻𝘆 𝗳𝗿𝗼𝗺 𝗗𝗿. 𝗩𝗮𝗹𝗲𝗻𝘁𝗶𝗻𝗮 𝗚𝘂𝗮𝗿𝗻𝗶𝗲𝗿𝗶, MD, Assistance at Immunology SOC Pediatric Clinic AOU Meyer IRCCS, Italy. Meyer Hospital is a cutting-edge center for the implementation of advanced screening program that identifies numerous congenital disorders, including SCID at an early stage, thanks to the availability of such screenings in the Tuscany Region. In this podcast Dr. Guarnieri highlights the 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐚𝐦𝐨𝐧𝐠 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐜𝐞𝐧𝐭𝐞𝐫𝐬 𝐚𝐧𝐝 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐄𝐮𝐫𝐨𝐩𝐞 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝 with the intent to exchange invaluable insights and share experiences and techniques. #InternationalNeonatalScreeningDay #INSD #NeonatalScreening #PrimaryImmunodeficiencies #NeonatalHealth #RareDiseases #NeonatalScreeningMatters

📅🇵🇹 𝑱𝒖𝒏𝒆 𝟮𝟴 | 𝑰𝒏𝒕𝒆𝒓𝒏𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝑵𝒆𝒐𝒏𝒂𝒕𝒂𝒍 𝑺𝒄𝒓𝒆𝒆𝒏𝒊𝒏𝒈 𝑫𝒂𝒚:  𝑨𝑷𝑫𝑰𝑷 𝒍𝒂𝒖𝒏𝒄𝒉𝒆𝒔 𝒑𝒆𝒕𝒊𝒕𝒊𝒐𝒏 𝒇𝒐𝒓 𝑺𝑪𝑰𝑫 𝒔𝒄𝒓𝒆𝒆𝒏𝒊𝒏𝒈 𝒊𝒏 𝒏𝒆𝒐𝒏𝒂𝒕𝒂𝒍 𝒉𝒆𝒆𝒍 𝒑𝒓𝒊𝒄𝒌 𝒕𝒆𝒔𝒕 𝒊𝒏 𝑷𝒐𝒓𝒕𝒖𝒈𝒂𝒍 On the occasion of the 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗡𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗗𝗮𝘆, the Portuguese Association of Patients with Primary Immunodeficiencies (APDIP) has launched a public petition for the inclusion of Severe Combined Immunodeficiency (SCID) in the neonatal screening to be carried out for all newborns in Portugal through the heel prick test. 𝐴𝑐𝑐𝑜𝑟𝑑𝑖𝑛𝑔 𝑡𝑜 𝑡ℎ𝑒 '𝑅𝑎𝑟𝑒 𝐵𝑎𝑟𝑜𝑚𝑒𝑡𝑒𝑟' 𝑠𝑢𝑟𝑣𝑒𝑦 𝑐𝑎𝑟𝑟𝑖𝑒𝑑 𝑜𝑢𝑡 𝑖𝑛 2023 𝑏𝑦 𝑡ℎ𝑒 𝐸𝑢𝑟𝑜𝑝𝑒𝑎𝑛 𝑂𝑟𝑔𝑎𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑅𝑎𝑟𝑒 𝐷𝑖𝑠𝑒𝑎𝑠𝑒𝑠 (𝐸𝑈𝑅𝑂𝑅𝐷𝐼𝑆) 𝑎𝑚𝑜𝑛𝑔 𝑚𝑜𝑟𝑒 𝑡ℎ𝑎𝑛 5,000 𝑝𝑒𝑜𝑝𝑙𝑒 𝑤𝑖𝑡ℎ 𝑟𝑎𝑟𝑒 𝑑𝑖𝑠𝑒𝑎𝑠𝑒𝑠 𝑎𝑛𝑑 𝑡ℎ𝑒𝑖𝑟 𝑓𝑎𝑚𝑖𝑙𝑖𝑒𝑠, 50% 𝑜𝑓 𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑒𝑛𝑡𝑠 𝑟𝑒𝑣𝑒𝑎𝑙𝑒𝑑 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒𝑦 𝑑𝑒𝑒𝑝𝑙𝑦 𝑎𝑔𝑟𝑒𝑒𝑑 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑝𝑜𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 𝑜𝑓 𝑡𝑟𝑎𝑐𝑘𝑖𝑛𝑔 𝑡ℎ𝑒 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑎𝑡 𝑏𝑖𝑟𝑡ℎ. 𝑇ℎ𝑒 𝑓𝑖𝑔𝑢𝑟𝑒 𝑖𝑠 𝑒𝑣𝑒𝑛 ℎ𝑖𝑔ℎ𝑒𝑟 𝑓𝑜𝑟 𝑝𝑎𝑟𝑒𝑛𝑡𝑠 𝑜𝑓 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝑙𝑖𝑣𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑟𝑎𝑟𝑒 𝑑𝑖𝑠𝑒𝑎𝑠𝑒𝑠, 𝑤𝑖𝑡ℎ 82% 𝑠𝑎𝑦𝑖𝑛𝑔 𝑡ℎ𝑒𝑦 𝑤𝑜𝑢𝑙𝑑 𝑙𝑖𝑘𝑒 𝑡ℎ𝑒𝑖𝑟 𝑐ℎ𝑖𝑙𝑑 𝑡𝑜 ℎ𝑎𝑣𝑒 𝑏𝑒𝑒𝑛 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑒𝑑 𝑎𝑡 𝑏𝑖𝑟𝑡ℎ.* SCID screening is already a reality in many countries. With current technology, integrating this test into other standard neonatal screenings is feasible and promises to transform lives. 🙌 As Kedrion, we share the commitment of APDIP in underscoring the critical role of early diagnosis for managing and treating serious Immunodeficiencies. IPOPI - International Patient Organisation for Primary Immunodeficiencies APDIP - Associação Portuguesa de Doentes com Imunodeficiências Primárias Ricardo 🍐 Pereira #InternationalNeonatalScreeningDay #INSD #NeonatalScreening #PrimaryImmunodeficiencies #NeonatalHealth #RareDiseases #NeonatalScreeningMatters  *"𝘙𝘢𝘳𝘦 𝘉𝘢𝘳𝘰𝘮𝘦𝘵𝘦𝘳" 𝘴𝘶𝘳𝘷𝘦𝘺 𝘣𝘺 EURORDIS-Rare Diseases Europe  https://lnkd.in/dRd5eD88

📅🇮🇹 𝐉𝐮𝐧𝐞 𝟐𝟖 | 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐃𝐚𝐲:  𝐀𝐈𝐏 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐭𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐮𝐧𝐢𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐏𝐈𝐃𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐈𝐭𝐚𝐥𝐲 As we approach International Neonatal Screening Day, 𝐭𝐡𝐞 𝐈𝐭𝐚𝐥𝐢𝐚𝐧 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐈𝐦𝐦𝐮𝐧𝐨𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐢𝐞𝐬 (𝐀𝐈𝐏) underlines the crucial importance of this campaign. Newborn screening represents a fundamental step for the early diagnosis of Primary Immunodeficiencies, conditions which, if not treated promptly, can put newborns' lives at risk. Thanks to newborn screening, Health Systems can: 🔍 Identify Immunodeficiencies from the first days of life, possible with affordable technology 🩺 Promptly activate appropriate treatments 👶 Guarantee newborns a better quality of life and healthy growth We invite everyone to spread awareness about the importance of this life-saving practice and to support ongoing implementation in the field of Primary Immunodeficiencies. #InternationalNeonatalScreeningDay #INSD #NeonatalScreening #PrimaryImmunodeficiencies #NeonatalHealth #RareDiseases #NeonatalScreeningMatters @international neonatal scree

✨🎉 𝟏𝟎𝟎 𝐲𝐞𝐚𝐫𝐬 𝐬𝐞𝐫𝐯𝐢𝐧𝐠 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐢𝐧 𝐇𝐮𝐧𝐠𝐚𝐫𝐲: #𝐭𝐡𝐫𝐨𝐰𝐛𝐚𝐜𝐤 𝐯𝐢𝐝𝐞𝐨 🇭🇺 We are thrilled to share the highlights of 𝐨𝐮𝐫 𝟏𝟎𝟎𝐭𝐡 𝐚𝐧𝐧𝐢𝐯𝐞𝐫𝐬𝐚𝐫𝐲 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐨𝐮𝐫 𝐆𝐨̈𝐝𝐨̈𝐥𝐥𝐨̋ 𝐩𝐥𝐚𝐧𝐭 𝐢𝐧 𝐇𝐮𝐧𝐠𝐚𝐫𝐲. This milestone marks a century of continuous innovation and dedication together with our team, donors, patients and partners. 📽️ The video captures the essence of our journey and the bright future ahead. Thank you to everyone who has been part of our story. Here's to the next 100 years! 🥂 https://lnkd.in/dJ6kZqdd 𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐦𝐨𝐦𝐞𝐧𝐭𝐬 𝐡𝐞𝐫𝐞.

Per garantire in Italia un accesso equo e uniforme alle terapie, bisogna rendere più attrattivo l’approvvigionamento di plasmaderivati. Le aziende farmaceutiche fanno già la loro parte investendo risorse crescenti per rendere disponibile un numero sempre maggiore di questi farmaci. Migliorando innovazione tecnologica ed efficienza produttiva. #HackDonor2024

Last year we were honoured to meet Jaina and Alina in one of our new collection centers in Prague - two sisters, in a desperate attempt to escape the war in Ukraine, seek refuge in the Czech Republic. Filled with a deep sense of gratitude towards the people who have welcomed them, they decide to give back by donating plasma at a local center. This story isn't just about donating plasma; it's about the community that comes together around a plasma center. It's about people who put humanity first and want to make a difference in the lives of those who will receive plasma-derived therapies. Their kindness shows that even in hardship, compassion prevails, reminding us of the power of collective action in making a difference. Watch the video to hear their words and join us in celebrating all the donors around the world, everyday. #WBDD2024 #Plasma #PlasmaDonation #Donors

🎉 Oggi celebra con noi la 𝐆𝐢𝐨𝐫𝐧𝐚𝐭𝐚 𝐌𝐨𝐧𝐝𝐢𝐚𝐥𝐞 𝐝𝐞𝐥 𝐃𝐨𝐧𝐚𝐭𝐨𝐫𝐞 𝐝𝐢 𝐒𝐚𝐧𝐠𝐮𝐞 𝐞 𝐝𝐢 𝐏𝐥𝐚𝐬𝐦𝐚! Un giorno fondamentale per onorare tutti coloro che, in Italia e nel mondo, con questo gesto di puro altruismo, assicurano la disponibilità di trattamenti per milioni di pazienti. Grazie per essere stati con noi in questo viaggio 🧳 e vi lasciamo con l’ultimo #PlasmaQuiz! #HackDonor2024 #WBDD2024 #Plasma #PlasmaDonation Farmindustria

💫🚲 Siamo alla quarta tappa del nostro viaggio del plasma! A un giorno dalla Giornata Mondiale del Donatore di Sangue e di Plasma, vi presentiamo anche oggi il nostro #PlasmaQuiz. 🎮 Dopo aver scoperto l’immenso valore della donazione, del plasma e il percorso che questa preziosa risorsa fa per diventare una terapia, approfondiamo le popolazioni di pazienti che aiuta. #HackDonor2024 #WBDD2024 #Plasma #PlasmaDonation Farmindustria

The President of IPOPI - International Patient Organisation for Primary Immunodeficiencies, Martine Pergent, during a symposium recently held in Turkey for a large audience of Turkish pediatric and adult immunologists, highlighted 𝐭𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐛𝐞𝐬𝐭 𝐦𝐚𝐧𝐚𝐠𝐢𝐧𝐠 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐈𝐦𝐦𝐮𝐧𝐨𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐢𝐧 𝐭𝐡𝐞 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐜𝐡𝐢𝐥𝐝𝐡𝐨𝐨𝐝 𝐭𝐨 𝐚𝐝𝐮𝐥𝐭𝐡𝐨𝐨𝐝 for a better quality of life of patients. This meeting, organized with the unconditional grant of Kedrion Biopharma, also involved 𝐏𝐫𝐨𝐟. 𝐃𝐫. 𝐎̈𝐦𝐮̈𝐫 𝐀𝐫𝐝𝐞𝐧𝐢𝐳, who chaired the symposium and explained 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐬𝐭𝐚𝐭𝐮𝐬 𝐨𝐟 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐈𝐦𝐦𝐮𝐧𝐨𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐢𝐞𝐬 𝐢𝐧 𝐓𝐮𝐫𝐤𝐞𝐲, which has a high incident rate and despite this there is still a lack of attention and importance given to this issue.